LITIAN PICTURES (09958) completed the issuance of a total of 72 million shares of placement shares.

20:49 04/02/2026

Li Tian Films (09958) announced that all conditions stipulated in the placing agreement have been met, and the placement was completed on February 4, 2026. A total of 72 million shares have been successfully placed at a price of HK$0.20 per share to no less than six placing agents, representing approximately 16.67% of the enlarged issued share capital of the company after completion of the placement.

Litian Pictures (09958) announced that all conditions set out in the placement agreement have been met, and the placement was completed on February 4, 2026. A total of 72 million shares (representing approximately 16.67% of the issued share capital of the company after the completion of the placement and the issuance of new shares) were successfully placed to no fewer than six subscribers at a price of HK$0.20 per share in accordance with the terms of the placement agreement.

INNOGEN-B(02591): The clinical trial application for the new veterinary drug Isubpagrulupeptide has been accepted.

The additional share purchase rights (02675) of EDGE MEDICAL-B have been exercised, marking the end of the stable price period.

US Stock Market Move | 2026 performance guidance greatly exceeds expectations, Eli Lilly (LLY.US) rises over 8% in pre-market trading.

INNOGEN-B(02591): The clinical trial application for the new veterinary drug Isubpagrulupeptide has been accepted.

The additional share purchase rights (02675) of EDGE MEDICAL-B have been exercised, marking the end of the stable price period.

US Stock Market Move | 2026 performance guidance greatly exceeds expectations, Eli Lilly (LLY.US) rises over 8% in pre-market trading.